APO Research
Talk to an analyst

APO RESEARCH · REPORT

Aurora Kinase B

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Aurora Kinase B Market Analysis and Forecast 2026-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchAurora Kinase B Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Aurora Kinase B Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Aurora Kinase B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aurora Kinase B Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Aurora Kinase B Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Aurora Kinase B market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Aurora Kinase B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Aurora Kinase B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Aurora Kinase B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Aurora Kinase B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Aurora Kinase B include Advenchen Laboratories LLC, Aeterna Zentaris Inc, Chipscreen Biosciences Ltd, Cielo Therapeutics Inc, Sareum Holdings Plc, AstraZeneca Plc, AbbVie Inc, Amgen Inc and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Aurora Kinase B, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Aurora Kinase B, also provides the sales of main regions and countries. Of the upcoming market potential for Aurora Kinase B, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Aurora Kinase B sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Aurora Kinase B market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Aurora Kinase B sales, projected growth trends, production technology, application and end-user industry.

Aurora Kinase B Segment by Company

Advenchen Laboratories LLC

Aeterna Zentaris Inc

Chipscreen Biosciences Ltd

Cielo Therapeutics Inc

Sareum Holdings Plc

AstraZeneca Plc

AbbVie Inc

Amgen Inc

Sanofi

Aurora Kinase B Segment by Type

Danusertib

NMI-900

Ilorasertib

CS-2164

AZD-2811

Others

Aurora Kinase B Segment by Application

Kidney Cancer

Prostate Cancer

Anaplastic Large Cell Lymphoma

Lung Cancer

Others

Aurora Kinase B Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aurora Kinase B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aurora Kinase B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aurora Kinase B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Aurora Kinase B in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Aurora Kinase B manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aurora Kinase B sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Aurora Kinase B Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Danusertib Major Manufacturers Table 3. NMI-900 Major Manufacturers Table 4. Ilorasertib Major Manufacturers Table 5. CS-2164 Major Manufacturers Table 6. AZD-2811 Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Aurora Kinase B Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Kidney Cancer Major Manufacturers Table 10. Prostate Cancer Major Manufacturers Table 11. Anaplastic Large Cell Lymphoma Major Manufacturers Table 12. Lung Cancer Major Manufacturers Table 13. Others Major Manufacturers Table 14. Aurora Kinase B Industry Trends Table 15. Aurora Kinase B Industry Drivers Table 16. Aurora Kinase B Industry Opportunities and Challenges Table 17. Aurora Kinase B Industry Restraints Table 18. Global Aurora Kinase B Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Aurora Kinase B Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Aurora Kinase B Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Aurora Kinase B Revenue Market Share by Region (2021-2026) Table 22. Global Aurora Kinase B Revenue Market Share by Region (2027-2032) Table 23. Global Aurora Kinase B Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 24. Global Aurora Kinase B Sales by Region (2021-2026) & (W Units) Table 25. Global Aurora Kinase B Sales by Region (2027-2032) & (W Units) Table 26. Global Aurora Kinase B Sales Market Share by Region (2021-2026) Table 27. Global Aurora Kinase B Sales Market Share by Region (2027-2032) Table 28. Global Aurora Kinase B Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Aurora Kinase B Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Aurora Kinase B Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Aurora Kinase B Sales Market Share by Manufacturers (2021-2026) Table 32. Global Aurora Kinase B Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 33. Global Aurora Kinase B Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Aurora Kinase B Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Aurora Kinase B Manufacturers, Product Type & Application Table 36. Global Aurora Kinase B Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Aurora Kinase B by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Aurora Kinase B Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Aurora Kinase B Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Aurora Kinase B Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Aurora Kinase B Revenue Market Share by Type (2021-2026) Table 43. Global Aurora Kinase B Revenue Market Share by Type (2027-2032) Table 44. Global Aurora Kinase B Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 45. Global Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 46. Global Aurora Kinase B Sales by Type (2027-2032) & (W Units) Table 47. Global Aurora Kinase B Sales Market Share by Type (2021-2026) Table 48. Global Aurora Kinase B Sales Market Share by Type (2027-2032) Table 49. Global Aurora Kinase B Price by Type (2021-2026) & (US$/Unit) Table 50. Global Aurora Kinase B Price by Type (2027-2032) & (US$/Unit) Table 51. Global Aurora Kinase B Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Aurora Kinase B Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Aurora Kinase B Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Aurora Kinase B Revenue Market Share by Application (2021-2026) Table 55. Global Aurora Kinase B Revenue Market Share by Application (2027-2032) Table 56. Global Aurora Kinase B Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 57. Global Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 58. Global Aurora Kinase B Sales by Application (2027-2032) & (W Units) Table 59. Global Aurora Kinase B Sales Market Share by Application (2021-2026) Table 60. Global Aurora Kinase B Sales Market Share by Application (2027-2032) Table 61. Global Aurora Kinase B Price by Application (2021-2026) & (US$/Unit) Table 62. Global Aurora Kinase B Price by Application (2027-2032) & (US$/Unit) Table 63. Advenchen Laboratories LLC Company Information Table 64. Advenchen Laboratories LLC Business Overview Table 65. Advenchen Laboratories LLC Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Advenchen Laboratories LLC Aurora Kinase B Product Portfolio Table 67. Advenchen Laboratories LLC Recent Development Table 68. Aeterna Zentaris Inc Company Information Table 69. Aeterna Zentaris Inc Business Overview Table 70. Aeterna Zentaris Inc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Aeterna Zentaris Inc Aurora Kinase B Product Portfolio Table 72. Aeterna Zentaris Inc Recent Development Table 73. Chipscreen Biosciences Ltd Company Information Table 74. Chipscreen Biosciences Ltd Business Overview Table 75. Chipscreen Biosciences Ltd Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Chipscreen Biosciences Ltd Aurora Kinase B Product Portfolio Table 77. Chipscreen Biosciences Ltd Recent Development Table 78. Cielo Therapeutics Inc Company Information Table 79. Cielo Therapeutics Inc Business Overview Table 80. Cielo Therapeutics Inc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Cielo Therapeutics Inc Aurora Kinase B Product Portfolio Table 82. Cielo Therapeutics Inc Recent Development Table 83. Sareum Holdings Plc Company Information Table 84. Sareum Holdings Plc Business Overview Table 85. Sareum Holdings Plc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sareum Holdings Plc Aurora Kinase B Product Portfolio Table 87. Sareum Holdings Plc Recent Development Table 88. AstraZeneca Plc Company Information Table 89. AstraZeneca Plc Business Overview Table 90. AstraZeneca Plc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. AstraZeneca Plc Aurora Kinase B Product Portfolio Table 92. AstraZeneca Plc Recent Development Table 93. AbbVie Inc Company Information Table 94. AbbVie Inc Business Overview Table 95. AbbVie Inc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AbbVie Inc Aurora Kinase B Product Portfolio Table 97. AbbVie Inc Recent Development Table 98. Amgen Inc Company Information Table 99. Amgen Inc Business Overview Table 100. Amgen Inc Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Amgen Inc Aurora Kinase B Product Portfolio Table 102. Amgen Inc Recent Development Table 103. Sanofi Company Information Table 104. Sanofi Business Overview Table 105. Sanofi Aurora Kinase B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Sanofi Aurora Kinase B Product Portfolio Table 107. Sanofi Recent Development Table 108. North America Aurora Kinase B Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Aurora Kinase B Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 111. North America Aurora Kinase B Sales by Type (2027-2032) & (W Units) Table 112. North America Aurora Kinase B Sales Price by Type (2021-2026) & (US$/Unit) Table 113. North America Aurora Kinase B Sales Price by Type (2027-2032) & (US$/Unit) Table 114. North America Aurora Kinase B Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Aurora Kinase B Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 117. North America Aurora Kinase B Sales by Application (2027-2032) & (W Units) Table 118. North America Aurora Kinase B Sales Price by Application (2021-2026) & (US$/Unit) Table 119. North America Aurora Kinase B Sales Price by Application (2027-2032) & (US$/Unit) Table 120. North America Aurora Kinase B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Aurora Kinase B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Aurora Kinase B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Aurora Kinase B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 124. North America Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 125. North America Aurora Kinase B Sales by Country (2027-2032) & (W Units) Table 126. North America Aurora Kinase B Sales Price by Country (2021-2026) & (US$/Unit) Table 127. North America Aurora Kinase B Sales Price by Country (2027-2032) & (US$/Unit) Table 128. United States Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 129. Canada Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 130. Europe Aurora Kinase B Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Aurora Kinase B Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 133. Europe Aurora Kinase B Sales by Type (2027-2032) & (W Units) Table 134. Europe Aurora Kinase B Sales Price by Type (2021-2026) & (US$/Unit) Table 135. Europe Aurora Kinase B Sales Price by Type (2027-2032) & (US$/Unit) Table 136. Europe Aurora Kinase B Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Aurora Kinase B Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 139. Europe Aurora Kinase B Sales by Application (2027-2032) & (W Units) Table 140. Europe Aurora Kinase B Sales Price by Application (2021-2026) & (US$/Unit) Table 141. Europe Aurora Kinase B Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Europe Aurora Kinase B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Aurora Kinase B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Aurora Kinase B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Aurora Kinase B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 146. Europe Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 147. Europe Aurora Kinase B Sales by Country (2027-2032) & (W Units) Table 148. Europe Aurora Kinase B Sales Price by Country (2021-2026) & (US$/Unit) Table 149. Europe Aurora Kinase B Sales Price by Country (2027-2032) & (US$/Unit) Table 150. Germany Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 151. France Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 152. U.K. Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 153. Italy Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 154. Netherlands Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 155. Nordic Countries Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 156. China Aurora Kinase B Revenue by Type (2021-2026) & (US$ Million) Table 157. China Aurora Kinase B Revenue by Type (2027-2032) & (US$ Million) Table 158. China Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 159. China Aurora Kinase B Sales by Type (2027-2032) & (W Units) Table 160. China Aurora Kinase B Sales Price by Type (2021-2026) & (US$/Unit) Table 161. China Aurora Kinase B Sales Price by Type (2027-2032) & (US$/Unit) Table 162. China Aurora Kinase B Revenue by Application (2021-2026) & (US$ Million) Table 163. China Aurora Kinase B Revenue by Application (2027-2032) & (US$ Million) Table 164. China Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 165. China Aurora Kinase B Sales by Application (2027-2032) & (W Units) Table 166. China Aurora Kinase B Sales Price by Application (2021-2026) & (US$/Unit) Table 167. China Aurora Kinase B Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Aurora Kinase B Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Aurora Kinase B Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 171. Asia Aurora Kinase B Sales by Type (2027-2032) & (W Units) Table 172. Asia Aurora Kinase B Sales Price by Type (2021-2026) & (US$/Unit) Table 173. Asia Aurora Kinase B Sales Price by Type (2027-2032) & (US$/Unit) Table 174. Asia Aurora Kinase B Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Aurora Kinase B Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 177. Asia Aurora Kinase B Sales by Application (2027-2032) & (W Units) Table 178. Asia Aurora Kinase B Sales Price by Application (2021-2026) & (US$/Unit) Table 179. Asia Aurora Kinase B Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia Aurora Kinase B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Aurora Kinase B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Aurora Kinase B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Aurora Kinase B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 184. Asia Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 185. Asia Aurora Kinase B Sales by Country (2027-2032) & (W Units) Table 186. Asia Aurora Kinase B Sales Price by Country (2021-2026) & (US$/Unit) Table 187. Asia Aurora Kinase B Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Japan Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 189. South Korea Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 190. India Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 191. Australia Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 192. China Taiwan Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Aurora Kinase B Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Aurora Kinase B Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Aurora Kinase B Sales by Type (2021-2026) & (W Units) Table 197. SAMEA Aurora Kinase B Sales by Type (2027-2032) & (W Units) Table 198. SAMEA Aurora Kinase B Sales Price by Type (2021-2026) & (US$/Unit) Table 199. SAMEA Aurora Kinase B Sales Price by Type (2027-2032) & (US$/Unit) Table 200. SAMEA Aurora Kinase B Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Aurora Kinase B Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Aurora Kinase B Sales by Application (2021-2026) & (W Units) Table 203. SAMEA Aurora Kinase B Sales by Application (2027-2032) & (W Units) Table 204. SAMEA Aurora Kinase B Sales Price by Application (2021-2026) & (US$/Unit) Table 205. SAMEA Aurora Kinase B Sales Price by Application (2027-2032) & (US$/Unit) Table 206. SAMEA Aurora Kinase B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Aurora Kinase B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Aurora Kinase B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Aurora Kinase B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 210. SAMEA Aurora Kinase B Sales by Country (2021-2026) & (W Units) Table 211. SAMEA Aurora Kinase B Sales by Country (2027-2032) & (W Units) Table 212. SAMEA Aurora Kinase B Sales Price by Country (2021-2026) & (US$/Unit) Table 213. SAMEA Aurora Kinase B Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Brazil Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 215. Argentina Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 216. Chile Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 217. Colombia Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 218. Peru Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 220. Israel Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 221. UAE Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 222. Turkey Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 223. Iran Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 224. Egypt Aurora Kinase B Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Aurora Kinase B Distributors List Table 228. Aurora Kinase B Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Aurora Kinase B Image Figure 2. Global Aurora Kinase B Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aurora Kinase B Market Size Share 2021 VS 2025 VS 2032 Figure 4. Danusertib Image Figure 5. NMI-900 Image Figure 6. Ilorasertib Image Figure 7. CS-2164 Image Figure 8. AZD-2811 Image Figure 9. Others Image Figure 10. Global Aurora Kinase B Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Aurora Kinase B Market Size Share 2021 VS 2025 VS 2032 Figure 12. Kidney Cancer Image Figure 13. Prostate Cancer Image Figure 14. Anaplastic Large Cell Lymphoma Image Figure 15. Lung Cancer Image Figure 16. Others Image Figure 17. Global Aurora Kinase B Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Aurora Kinase B Revenue (2021-2032) & (US$ Million) Figure 19. Global Aurora Kinase B Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Aurora Kinase B Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Aurora Kinase B Revenue Market Share by Region (2021-2032) Figure 22. Global Aurora Kinase B Sales (2021-2032) & (W Units) Figure 23. Global Aurora Kinase B Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 24. Global Aurora Kinase B Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Aurora Kinase B Sales YoY (2021-2032) & (W Units) Figure 26. Europe Aurora Kinase B Sales YoY (2021-2032) & (W Units) Figure 27. China Aurora Kinase B Sales YoY (2021-2032) & (W Units) Figure 28. Asia (Excluding China) Aurora Kinase B Sales YoY (2021-2032) & (W Units) Figure 29. South America, Middle East and Africa Aurora Kinase B Sales YoY (2021-2032) & (W Units) Figure 30. Global Aurora Kinase B Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Aurora Kinase B Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Aurora Kinase B Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Aurora Kinase B Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Aurora Kinase B Revenue Market Share by Type (2021-2032) Figure 36. Global Aurora Kinase B Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Aurora Kinase B Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Aurora Kinase B Sales Market Share by Type (2021-2032) Figure 39. Global Aurora Kinase B Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Aurora Kinase B Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Aurora Kinase B Revenue Market Share by Application (2021-2032) Figure 42. Global Aurora Kinase B Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 43. Global Aurora Kinase B Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Aurora Kinase B Sales Market Share by Application (2021-2032) Figure 45. North America Aurora Kinase B Revenue Share by Type (2021-2032) Figure 46. North America Aurora Kinase B Sales Share by Type (2021-2032) Figure 47. North America Aurora Kinase B Revenue Share by Application (2021-2032) Figure 48. North America Aurora Kinase B Sales Share by Application (2021-2032) Figure 49. North America Aurora Kinase B Revenue Share by Country (2021-2032) Figure 50. North America Aurora Kinase B Sales Share by Country (2021-2032) Figure 51. Europe Aurora Kinase B Revenue Share by Type (2021-2032) Figure 52. Europe Aurora Kinase B Sales Share by Type (2021-2032) Figure 53. Europe Aurora Kinase B Revenue Share by Application (2021-2032) Figure 54. Europe Aurora Kinase B Sales Share by Application (2021-2032) Figure 55. Europe Aurora Kinase B Revenue Share by Country (2021-2032) Figure 56. Europe Aurora Kinase B Sales Share by Country (2021-2032) Figure 57. China Aurora Kinase B Revenue Share by Type (2021-2032) Figure 58. China Aurora Kinase B Sales Share by Type (2021-2032) Figure 59. China Aurora Kinase B Revenue Share by Application (2021-2032) Figure 60. China Aurora Kinase B Sales Share by Application (2021-2032) Figure 61. Asia Aurora Kinase B Revenue Share by Type (2021-2032) Figure 62. Asia Aurora Kinase B Sales Share by Type (2021-2032) Figure 63. Asia Aurora Kinase B Revenue Share by Application (2021-2032) Figure 64. Asia Aurora Kinase B Sales Share by Application (2021-2032) Figure 65. Asia Aurora Kinase B Revenue Share by Country (2021-2032) Figure 66. Asia Aurora Kinase B Sales Share by Country (2021-2032) Figure 67. SAMEA Aurora Kinase B Revenue Share by Type (2021-2032) Figure 68. SAMEA Aurora Kinase B Sales Share by Type (2021-2032) Figure 69. SAMEA Aurora Kinase B Revenue Share by Application (2021-2032) Figure 70. SAMEA Aurora Kinase B Sales Share by Application (2021-2032) Figure 71. SAMEA Aurora Kinase B Revenue Share by Country (2021-2032) Figure 72. SAMEA Aurora Kinase B Sales Share by Country (2021-2032) Figure 73. Aurora Kinase B Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Aurora Kinase B Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Danusertib
  • NMI-900
  • Ilorasertib
  • CS-2164
  • AZD-2811
  • Others
Applications
  • Kidney Cancer
  • Prostate Cancer
  • Anaplastic Large Cell Lymphoma
  • Lung Cancer
  • Others
Companies covered
  • Advenchen Laboratories LLC
  • Aeterna Zentaris Inc
  • Chipscreen Biosciences Ltd
  • Cielo Therapeutics Inc
  • Sareum Holdings Plc
  • AstraZeneca Plc
  • AbbVie Inc
  • Amgen Inc
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Aurora Kinase B Market by Type
  3. 1.2.1 Global Aurora Kinase B Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Danusertib
  5. 1.2.3 NMI-900
  6. 1.2.4 Ilorasertib
  7. 1.2.5 CS-2164
  8. 1.2.6 AZD-2811
  9. 1.2.7 Others
  10. 1.3 Aurora Kinase B Market by Application
  11. 1.3.1 Global Aurora Kinase B Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Kidney Cancer
  13. 1.3.3 Prostate Cancer
  14. 1.3.4 Anaplastic Large Cell Lymphoma
  15. 1.3.5 Lung Cancer
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Aurora Kinase B Market Dynamics
  1. 2.1 Aurora Kinase B Industry Trends
  2. 2.2 Aurora Kinase B Industry Drivers
  3. 2.3 Aurora Kinase B Industry Opportunities and Challenges
  4. 2.4 Aurora Kinase B Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Aurora Kinase B Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Aurora Kinase B Revenue by Region
  3. 3.2.1 Global Aurora Kinase B Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Aurora Kinase B Revenue by Region (2021-2026)
  5. 3.2.3 Global Aurora Kinase B Revenue by Region (2027-2032)
  6. 3.2.4 Global Aurora Kinase B Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Aurora Kinase B Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Aurora Kinase B Sales by Region
  9. 3.4.1 Global Aurora Kinase B Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Aurora Kinase B Sales by Region (2021-2026)
  11. 3.4.3 Global Aurora Kinase B Sales by Region (2027-2032)
  12. 3.4.4 Global Aurora Kinase B Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Aurora Kinase B Revenue by Manufacturers
  2. 4.1.1 Global Aurora Kinase B Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Aurora Kinase B Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Aurora Kinase B Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Aurora Kinase B Sales by Manufacturers
  6. 4.2.1 Global Aurora Kinase B Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Aurora Kinase B Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Aurora Kinase B Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Aurora Kinase B Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Aurora Kinase B Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Aurora Kinase B Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Aurora Kinase B Manufacturers, Product Type & Application
  13. 4.7 Global Aurora Kinase B Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Aurora Kinase B Market CR5 and HHI
  16. 4.8.2 2025 Aurora Kinase B Tier 1, Tier 2, and Tier 3
5 Aurora Kinase B Market by Type
  1. 5.1 Global Aurora Kinase B Revenue by Type
  2. 5.1.1 Global Aurora Kinase B Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Aurora Kinase B Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Aurora Kinase B Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Aurora Kinase B Sales by Type
  6. 5.2.1 Global Aurora Kinase B Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Aurora Kinase B Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Aurora Kinase B Sales Market Share by Type (2021-2032)
  9. 5.3 Global Aurora Kinase B Price by Type
6 Aurora Kinase B Market by Application
  1. 6.1 Global Aurora Kinase B Revenue by Application
  2. 6.1.1 Global Aurora Kinase B Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Aurora Kinase B Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Aurora Kinase B Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Aurora Kinase B Sales by Application
  6. 6.2.1 Global Aurora Kinase B Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Aurora Kinase B Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Aurora Kinase B Sales Market Share by Application (2021-2032)
  9. 6.3 Global Aurora Kinase B Price by Application
7 Company Profiles
  1. 7.1 Advenchen Laboratories LLC
  2. 7.1.1 Advenchen Laboratories LLC Company Information
  3. 7.1.2 Advenchen Laboratories LLC Business Overview
  4. 7.1.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Advenchen Laboratories LLC Aurora Kinase B Product Portfolio
  6. 7.1.5 Advenchen Laboratories LLC Recent Developments
  7. 7.2 Aeterna Zentaris Inc
  8. 7.2.1 Aeterna Zentaris Inc Company Information
  9. 7.2.2 Aeterna Zentaris Inc Business Overview
  10. 7.2.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aeterna Zentaris Inc Aurora Kinase B Product Portfolio
  12. 7.2.5 Aeterna Zentaris Inc Recent Developments
  13. 7.3 Chipscreen Biosciences Ltd
  14. 7.3.1 Chipscreen Biosciences Ltd Company Information
  15. 7.3.2 Chipscreen Biosciences Ltd Business Overview
  16. 7.3.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Chipscreen Biosciences Ltd Aurora Kinase B Product Portfolio
  18. 7.3.5 Chipscreen Biosciences Ltd Recent Developments
  19. 7.4 Cielo Therapeutics Inc
  20. 7.4.1 Cielo Therapeutics Inc Company Information
  21. 7.4.2 Cielo Therapeutics Inc Business Overview
  22. 7.4.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Cielo Therapeutics Inc Aurora Kinase B Product Portfolio
  24. 7.4.5 Cielo Therapeutics Inc Recent Developments
  25. 7.5 Sareum Holdings Plc
  26. 7.5.1 Sareum Holdings Plc Company Information
  27. 7.5.2 Sareum Holdings Plc Business Overview
  28. 7.5.3 Sareum Holdings Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sareum Holdings Plc Aurora Kinase B Product Portfolio
  30. 7.5.5 Sareum Holdings Plc Recent Developments
  31. 7.6 AstraZeneca Plc
  32. 7.6.1 AstraZeneca Plc Company Information
  33. 7.6.2 AstraZeneca Plc Business Overview
  34. 7.6.3 AstraZeneca Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Plc Aurora Kinase B Product Portfolio
  36. 7.6.5 AstraZeneca Plc Recent Developments
  37. 7.7 AbbVie Inc
  38. 7.7.1 AbbVie Inc Company Information
  39. 7.7.2 AbbVie Inc Business Overview
  40. 7.7.3 AbbVie Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 AbbVie Inc Aurora Kinase B Product Portfolio
  42. 7.7.5 AbbVie Inc Recent Developments
  43. 7.8 Amgen Inc
  44. 7.8.1 Amgen Inc Company Information
  45. 7.8.2 Amgen Inc Business Overview
  46. 7.8.3 Amgen Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Amgen Inc Aurora Kinase B Product Portfolio
  48. 7.8.5 Amgen Inc Recent Developments
  49. 7.9 Sanofi
  50. 7.9.1 Sanofi Company Information
  51. 7.9.2 Sanofi Business Overview
  52. 7.9.3 Sanofi Aurora Kinase B Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sanofi Aurora Kinase B Product Portfolio
  54. 7.9.5 Sanofi Recent Developments
8 North America
  1. 8.1 North America Aurora Kinase B Market Size by Type
  2. 8.1.1 North America Aurora Kinase B Revenue by Type (2021-2032)
  3. 8.1.2 North America Aurora Kinase B Sales by Type (2021-2032)
  4. 8.1.3 North America Aurora Kinase B Price by Type (2021-2032)
  5. 8.2 North America Aurora Kinase B Market Size by Application
  6. 8.2.1 North America Aurora Kinase B Revenue by Application (2021-2032)
  7. 8.2.2 North America Aurora Kinase B Sales by Application (2021-2032)
  8. 8.2.3 North America Aurora Kinase B Price by Application (2021-2032)
  9. 8.3 North America Aurora Kinase B Market Size by Country
  10. 8.3.1 North America Aurora Kinase B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Aurora Kinase B Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Aurora Kinase B Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Aurora Kinase B Market Size by Type
  2. 9.1.1 Europe Aurora Kinase B Revenue by Type (2021-2032)
  3. 9.1.2 Europe Aurora Kinase B Sales by Type (2021-2032)
  4. 9.1.3 Europe Aurora Kinase B Price by Type (2021-2032)
  5. 9.2 Europe Aurora Kinase B Market Size by Application
  6. 9.2.1 Europe Aurora Kinase B Revenue by Application (2021-2032)
  7. 9.2.2 Europe Aurora Kinase B Sales by Application (2021-2032)
  8. 9.2.3 Europe Aurora Kinase B Price by Application (2021-2032)
  9. 9.3 Europe Aurora Kinase B Market Size by Country
  10. 9.3.1 Europe Aurora Kinase B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Aurora Kinase B Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Aurora Kinase B Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Aurora Kinase B Market Size by Type
  2. 10.1.1 China Aurora Kinase B Revenue by Type (2021-2032)
  3. 10.1.2 China Aurora Kinase B Sales by Type (2021-2032)
  4. 10.1.3 China Aurora Kinase B Price by Type (2021-2032)
  5. 10.2 China Aurora Kinase B Market Size by Application
  6. 10.2.1 China Aurora Kinase B Revenue by Application (2021-2032)
  7. 10.2.2 China Aurora Kinase B Sales by Application (2021-2032)
  8. 10.2.3 China Aurora Kinase B Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Aurora Kinase B Market Size by Type
  2. 11.1.1 Asia Aurora Kinase B Revenue by Type (2021-2032)
  3. 11.1.2 Asia Aurora Kinase B Sales by Type (2021-2032)
  4. 11.1.3 Asia Aurora Kinase B Price by Type (2021-2032)
  5. 11.2 Asia Aurora Kinase B Market Size by Application
  6. 11.2.1 Asia Aurora Kinase B Revenue by Application (2021-2032)
  7. 11.2.2 Asia Aurora Kinase B Sales by Application (2021-2032)
  8. 11.2.3 Asia Aurora Kinase B Price by Application (2021-2032)
  9. 11.3 Asia Aurora Kinase B Market Size by Country
  10. 11.3.1 Asia Aurora Kinase B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Aurora Kinase B Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Aurora Kinase B Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Aurora Kinase B Market Size by Type
  2. 12.1.1 SAMEA Aurora Kinase B Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Aurora Kinase B Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Aurora Kinase B Price by Type (2021-2032)
  5. 12.2 SAMEA Aurora Kinase B Market Size by Application
  6. 12.2.1 SAMEA Aurora Kinase B Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Aurora Kinase B Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Aurora Kinase B Price by Application (2021-2032)
  9. 12.3 SAMEA Aurora Kinase B Market Size by Country
  10. 12.3.1 SAMEA Aurora Kinase B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Aurora Kinase B Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Aurora Kinase B Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Aurora Kinase B Value Chain Analysis
  2. 13.1.1 Aurora Kinase B Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Aurora Kinase B Production Mode & Process
  6. 13.2 Aurora Kinase B Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Aurora Kinase B Distributors
  9. 13.2.3 Aurora Kinase B Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst